Skip to main content

Bacteria-fighting startup Pattern Bioscience raises nearly $29M

For years, we've known about how antibiotic resistant infections can damage our bodies and lead to huge expenses across the health care ecosystem. An Austin company is hoping to make a big difference on this front. Pattern Bioscience uses single-cell microbiology technology that doesn't require lengthy timeframes for bacteria to culture and quickly gives doctors the information they need to prescribe effective antibiotics.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.